MedPacto Statistics
Total Valuation
MedPacto has a market cap or net worth of KRW 125.28 billion. The enterprise value is 95.45 billion.
Important Dates
The next estimated earnings date is Friday, March 19, 2027.
| Earnings Date | Mar 19, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
MedPacto has 34.28 million shares outstanding. The number of shares has increased by 0.33% in one year.
| Current Share Class | 34.28M |
| Shares Outstanding | 34.28M |
| Shares Change (YoY) | +0.33% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 11.97% |
| Owned by Institutions (%) | 0.15% |
| Float | 25.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26.10 |
| PB Ratio | 3.49 |
| P/TBV Ratio | 3.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 19.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.51, with a Debt / Equity ratio of 0.04.
| Current Ratio | 23.51 |
| Quick Ratio | 22.31 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -120.64 |
Financial Efficiency
Return on equity (ROE) is -31.66% and return on invested capital (ROIC) is -20.49%.
| Return on Equity (ROE) | -31.66% |
| Return on Assets (ROA) | -29.67% |
| Return on Invested Capital (ROIC) | -20.49% |
| Return on Capital Employed (ROCE) | -38.92% |
| Weighted Average Cost of Capital (WACC) | 4.89% |
| Revenue Per Employee | 85.70M |
| Profits Per Employee | -238.21M |
| Employee Count | 56 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 7.71 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.50% in the last 52 weeks. The beta is 0.11, so MedPacto's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -53.50% |
| 50-Day Moving Average | 3,188.70 |
| 200-Day Moving Average | 3,987.68 |
| Relative Strength Index (RSI) | 52.65 |
| Average Volume (20 Days) | 655,088 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedPacto had revenue of KRW 4.80 billion and -13.34 billion in losses. Loss per share was -389.03.
| Revenue | 4.80B |
| Gross Profit | 371.09M |
| Operating Income | -14.34B |
| Pretax Income | -13.34B |
| Net Income | -13.34B |
| EBITDA | -13.28B |
| EBIT | -14.34B |
| Loss Per Share | -389.03 |
Full Income Statement Balance Sheet
The company has 31.17 billion in cash and 1.35 billion in debt, with a net cash position of 29.83 billion or 870.22 per share.
| Cash & Cash Equivalents | 31.17B |
| Total Debt | 1.35B |
| Net Cash | 29.83B |
| Net Cash Per Share | 870.22 |
| Equity (Book Value) | 35.88B |
| Book Value Per Share | 1,041.56 |
| Working Capital | 33.48B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -11.22 billion and capital expenditures -57.72 million, giving a free cash flow of -11.28 billion.
| Operating Cash Flow | -11.22B |
| Capital Expenditures | -57.72M |
| Depreciation & Amortization | 1.06B |
| Net Borrowing | -651.37M |
| Free Cash Flow | -11.28B |
| FCF Per Share | -329.07 |
Full Cash Flow Statement Margins
Gross margin is 7.73%, with operating and profit margins of -298.80% and -277.97%.
| Gross Margin | 7.73% |
| Operating Margin | -298.80% |
| Pretax Margin | -277.97% |
| Profit Margin | -277.97% |
| EBITDA Margin | -276.65% |
| EBIT Margin | -298.80% |
| FCF Margin | n/a |
Dividends & Yields
MedPacto does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.33% |
| Shareholder Yield | -0.33% |
| Earnings Yield | -10.64% |
| FCF Yield | -9.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on May 13, 2020. It was a forward split with a ratio of 2.
| Last Split Date | May 13, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
MedPacto has an Altman Z-Score of 31.19 and a Piotroski F-Score of 2.
| Altman Z-Score | 31.19 |
| Piotroski F-Score | 2 |